| Abstrakt: |
A recent study conducted in New Delhi, India, aimed to determine the incidence and reversibility of contrast-induced nephropathy (CIN) in patients undergoing high-risk percutaneous coronary intervention (PCI). The study included 50 consecutive cases and found that the incidence of CIN in high-risk PCI cases was 18%. Age above 70 years, hypertension, and diabetes were identified as significant predictors of CIN development. However, all cases of CIN had a self-limiting course and did not require renal replacement therapy. The study concluded that CIN affects approximately one out of every five to six high-risk PCI cases, but it is reversible. Patients with preexisting comorbidities such as diabetes and hypertension have a higher risk of developing CIN. [Extracted from the article] |
